Startups
The Wellcome Trust Limited
The Wellcome Trust Limited is the active UK company limited by guarantee (company02711000, incorporated24April1992) that acts as sole corporate trustee of the Wellcome Trust, the independent charitable foundation established in1936 by Sir Henry Wellcome’s bequest (charity210183). This institutional profile identifies the exact trustee named in Alto Neuroscience’s convertible-grant financing, while describing its publicly branded Wellcome investment platform and governance. Wellcome invests its endowment across public equities, private equity, venture capital, property and other financial assets, using returns to support discovery research and health including mental health, neuroscience, infectious disease, climate and health. Its in-house investment division is led by managing partners and co-chief investment officers Lisha Patel and Fabian Thehos, with four published principals and a separate investment committee of staff, governors and external experts. Investment committee memberships are governance affiliations rather than claims that every member is an employee of the legal trustee. The1936 charity founding and1992 company incorporation are distinct. The reported GBP39.9billion investment portfolio is net portfolio value, not an externally closed venture fund. Wellcome does not publicly raise charitable donations; endowment assets, spending commitments, borrowing and conditional research-grant facilities are not treated as LP fundraising or fully funded cash. Alto’s USD2million funded execution tranche is separate from its conditional up-to-USD11.7million facility.
Founded 1992
Team
 Cressida HoggMember — Wellcome Investment Committee |
 Diana NobleMember — Wellcome Investment Committee |
 Elaina ElzingaPrincipal — Wellcome investment division |
 Fabian ThehosManaging Partner and Co-Chief Investment Officer — Wellcome investment division · Member — Wellcome Investment Committee |
 Geoffrey LovePrincipal — Wellcome investment division |
 Girish ReddyMember — Wellcome Investment Committee |
 Hanneke SmitsMember — Wellcome Investment Committee |
 John-Arne RøttingenMember — Wellcome Investment Committee |
 Julia GillardMember — Wellcome Investment Committee |
 Lisha PatelManaging Partner and Co-Chief Investment Officer — Wellcome investment division · Member — Wellcome Investment Committee |
 Maggy ChanMember — Wellcome Investment Committee |
 Martin HalusaMember — Wellcome Investment Committee |
 Richard GillingwaterChair — Wellcome Investment Committee |
 Robert CokePrincipal — Wellcome investment division |
 Robert HollPrincipal — Wellcome investment division |
 Sandra RobertsonMember — Wellcome Investment Committee |
 Tracy BlackwellMember — Wellcome Investment Committee |
Investments
| £5MUnknown date |  Wysa | The Wellcome Trust Limited |
| £169MUnknown date |  Syncona Limited | The Wellcome Trust Limited |
| $2MUnknown date |  Alto Neuroscience | The Wellcome Trust Limited |